FDA Protocol Reviews Would Include Outside Consultants Under PDUFA III
This article was originally published in The Tan Sheet
Executive Summary
The PDUFA III agreement between FDA and industry includes a provision that would allow sponsors to request the participation of outside consultants in protocol design meetings
You may also be interested in...
PDUFA III Deal Includes Risk Management Fees In “Peri-Approval” Phase
The FDA/industry PDUFA III agreement includes funding to expand FDA's Office of Drug Safety by 100 full-time equivalent staff positions over five years
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands